Pages that link to "Q46595383"

The following pages link to A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia (Q46595383):

Displaying 19 items.

• An epidemiological study of concomitant use of Chinese medicine and antipsychotics in schizophrenic patients: implication for herb-drug interaction (Q28477174) (← links)
• The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. (Q33619940) (← links)
• World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects (Q34315836) (← links)
• Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials (Q34925151) (← links)
• Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin). (Q34966395) (← links)
• The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings (Q35369968) (← links)
• Strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review (Q38005470) (← links)
• Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review (Q38201749) (← links)
• The application status of Chinese herbal medicine in military health service in China (Q38564744) (← links)
• Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials (Q38858121) (← links)
• 18beta-glycyrrhetinic acid induces apoptosis in pituitary adenoma cells via ROS/MAPKs-mediated pathway (Q39070051) (← links)
• Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics. (Q39149871) (← links)
• Liquiritigenin exhibits antitumour action in pituitary adenoma cells via Ras/ERKs and ROS-dependent mitochondrial signalling pathways (Q46937181) (← links)
• Effect of Peony-Glycyrrhiza Decoction on Amisulpride-Induced Hyperprolactinemia in Women with Schizophrenia: A Preliminary Study (Q47556007) (← links)
• Male Reproductive Functions Disrupted by Pharmacological Agents. (Q52687141) (← links)
• In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism. (Q53802284) (← links)
• Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats (Q89314025) (← links)
• Adjunctive Peony-Glycyrrhiza decoction for antipsychotic-induced hyperprolactinaemia: a meta-analysis of randomised controlled trials (Q90733150) (← links)
• Interventions for antipsychotic‐induced amenorrhoea (Q94325612) (← links)